Novel and selective small molecule inhibitors and activators for the prolyl hydroxylase domain enzyme by Holt-Martyn, J

Pharmacological targeting of the HIF hydroxylases - A new field in medicine development. by Chan, M, Holt-Martyn, J, Schofield, C, Ratcliffe, P

Inhibition of JMJD6 by 2-oxoglutarate mimics by Islam, MS, Thinnes, C, Holt-Martyn, J, Chowdhury, R, McDonough, M, Schofield, C

Studies on spiro[4.5]decanone prolyl hydroxylase domain inhibitors by Holt-Martyn, J, Tumber, A, Rahman, M, Lippl, K, Figg, W, McDonough, M, Chowdhury, R, Schofield, C

A genomic DNA reporter screen identifies squalene synthase inhibitors which act cooperatively with statins to upregulate the low-density lipoprotein receptor by Kerr, A, Tam, L, Hale, A, Cioroch, M, Douglas, G, Agkatsev, S, Hibbit, O, Mason, J, Holt-Martyn, J, Bataille, C, Wynne, G, Channon, K, Russell, A, Wade-Martins, R

Potent and selective triazole-based inhibitors of the hypoxia-inducible factor prolyl-hydroxylases with activity in the murine brain by Chan, MC, Atasoylu, O, Hodson, E, Tumber, A, Leung, IKH, Chowdhury, R, Gómez-Pérez, V, Demetriades, M, Rydzik, AM, Holt-Martyn, J, Tian, Y-M, Bishop, T, Claridge, TDW, Kawamura, A, Pugh, CW, Ratcliffe, PJ, Schofield, CJ